NOVEL 6-ARYLAMINO PYRIDONE CARBOXAMIDE AS MEK INHIBITORS
申请人:Xiao Dengming
公开号:US20140080804A1
公开(公告)日:2014-03-20
The invention provides novel substituted 6-arylamino pyridone carboxamides represented by Formula I, or a pharmaceutically acceptable salt, solvate, poly-morph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of MEK and are useful in the treatment of inflammatory diseases, cancer and other hyperproliferative diseases. The invention further provides a method of treatment for inflammatory diseases, cancer and other hyperproliferative diseases in mammals, especially humans.
6-ARYLAMINO PYRIDONE CARBOXAMIDE AS MEK INHIBITORS
申请人:Centaurus BioPharma Co., Ltd.
公开号:EP2635587B1
公开(公告)日:2017-02-15
US9540396B2
申请人:——
公开号:US9540396B2
公开(公告)日:2017-01-10
[EN] NOVEL 6-ARYLAMINO PYRIDONE CARBOXAMIDE AS MEK INHIBITORS<br/>[FR] NOUVEAUX 6-ARYLAMINOPYRIDONECARBOXAMIDES COMME INHIBITEURS DE MEK
申请人:CENTAURUS BIOPHARMA CO LTD
公开号:WO2012059041A1
公开(公告)日:2012-05-10
The invention provides novel substituted 6-arylamino pyridone carboxamides represented by Formula I, or a pharmaceutically acceptable salt, solvate, poly- morph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of MEK and are useful in the treatment of inflammatory diseases, cancer and other hyperproliferative diseases. The invention further provides a method of treatment for inflammatory diseases, cancer and other hyperproliferative diseases in mammals, especially humans.